Searched for
RETIREMENT IN OPHTHALMOLOGY
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...- Must explore how AFMS can make meaningful contribution in domain of clinical trials: Rajnath SinghDefence Minister Rajnath Singh highlighted the need for clinical trial reforms in India. He suggested the Armed Forces Medical Services can...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%As nothing can be ruled out on the street, investors should be prepared for anything. Now, what is the probability that the bears will be c...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of at least 25%After a year of clear bearish bias, it appears that Nifty and Sensex are making serious attempts to move out into a different territory. No...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere is, somehow, a belief on the street that the recent decline seen in the stock market is largely due to domestic reasons. We seem to h...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 30%2025 has not been an easy year for the bulls. When we say bulls, we include retail investors. That’s because all retail investors are, by n...
- As Nifty & Sensex move higher, these large-cap stocks have ‘strong buy’, ‘buy’ recos, with an upside potential of more than 28%Here’s an old market saying that we like to quote often: Even when the bulls are in control, you can never write off the bears. Why? Becaus...
- Light after shells: How Indian Army doctors gave new vision to civilians caught in Pakistam's fury post Op SindoorAn advanced surgical eye camp in Udhampur brought sight to many. Over 1500 people were screened. More than 400 surgeries were performed. Th...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have a big element of probability. The way things have panned out in the past few weeks, it is very likely that the bulls will ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%All long-term investors know that corrections are part of every bull run. But, it is important to know whether they are caused by global or...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%On Monday, market breadth remained positive, even as the Nifty and Ssensex came under pressure, indicating the underlying bullish sentiment...
- These large- and mid-cap stocks can give more than 27% return in 1 year, according to analystsNothing can, or should, be ruled out on the street. Be prepared for anything. Now, what is the probability that the bears will be banished ...
- Padma Shri awardee Dr. Jeewan Singh Titiyal retires after 46 years of service at AIIMS, farewell video goes viralDr. Jeewan Singh Titiyal has retired from AIIMS, Delhi, concluding a notable 46-year career in eye care and medical education. Colleagues b...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The way 2024 is ending for large-caps is very different from how it began. At the start of the year, large-caps were mostly seen as stocks ...
- These large-caps have ‘Strong Buy’ & ‘Buy’ recos and an upside potential of more than 29%It is after a long time that we are seeing corrections in absolute terms. Also, it is rare for the Indian markets not to be in step as glob...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%Today because the nifty is trading in the red territory, the word correction might be heard on the street but the fact is that for the last...
- Sankara Nethralaya founder Dr SS Badrinath, who made eye care affordable, passes away at 83Dr Sengamedu Srinivasa Badrinath, the founder of Sankara Nethralaya, passed away at the age of 83. He dedicated his life to improving acces...
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market continues to recover, analysts are bullish on select large cap stock. Making to the list are a host of comp...
- Sun Pharma eyes China, Japan marketsShanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and...
- How a patient changed the way engineering is used in Indian ophthalmologyRichhariya first asked Sangwan about corneal dystrophy, the genetic disease he was suffering from, where unwanted material gets accumulated...
Load More
